OTCMKTS:CHEOF Cochlear (CHEOF) Stock Price, News & Analysis → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free CHEOF Stock Alerts $204.04 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$204.04▼$204.0450-Day Range$204.04▼$230.4652-Week Range$145.73▼$230.46VolumeN/AAverage Volume164 shsMarket CapitalizationN/AP/E Ratio124.26Dividend Yield0.62%Price TargetN/A Stock AnalysisStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Get Cochlear alerts: Email Address Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 About Cochlear Stock (OTCMKTS:CHEOF)Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.Read More CHEOF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CHEOF Stock News HeadlinesApril 19, 2024 | americanbankingnews.comCochlear (OTCMKTS:CHEOF) Stock Price Down 0.5%July 26, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Terns Pharmaceuticals (TERN) and Cochlear Limited (OtherCHEOF)April 25, 2024 | DTI (Ad)A new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… July 20, 2023 | msn.comChandy’s Cochlear Implant Scheme hits hurdles, parents seek government helpJuly 19, 2023 | benzinga.comSensorion Submits Clinical Trial Application for OTOF-GT, its Lead Gene Therapy Candidate, in EuropeJuly 18, 2023 | msn.com7-year-old girl hears for first time after Chhattisgarh govt sponsors operation, father wants her to become doctorJuly 18, 2023 | msn.comOommen Chandy: Humane leader who put patients first, say health expertsJuly 10, 2023 | markets.businessinsider.comMorgan Stanley Keeps Their Hold Rating on Cochlear Limited (CHEOF)April 25, 2024 | DTI (Ad)A new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… July 10, 2023 | benzinga.comSensorion Submits Clinical Trial Application for Lead Gene Therapy Candidate OTOF-GT in the UKJuly 5, 2023 | benzinga.comSensorion Reports Positive Efficacy Data from SENS-401 Phase 2a Clinical StudyJune 25, 2023 | msn.comRajasthan: Govt announces ₹1 lakh airfare for travel for organ transplantJune 25, 2023 | thetimes.co.ukNHS may have missed thousands of deaf children in ‘huge national failure’June 22, 2023 | morningstar.comFTSE 100 Closes Down 0.75% After Rate Hike; Ocado Surges on Bid SpeculationJune 22, 2023 | afr.comLabor bows to pressure on multinational tax disclosureJune 19, 2023 | finance.yahoo.comSensorion Reports Promising Preliminary Data from SENS-401 Phase 2a Clinical StudyMay 22, 2023 | afr.com‘Next Cochlear’ stock surges after heart device breakthroughMay 4, 2023 | marketwatch.comCochlear Implants Market Share | Business till 2030May 3, 2023 | msn.comParents to inform SA cochlear implant reviewApril 20, 2023 | msn.comTownsville University Hospital staff stood down amid review of paediatric audiology unit outcomesApril 16, 2023 | afr.comAustralian business delegation heads to ChinaApril 11, 2023 | msn.comSurgeries of chronically ill children in Pune pending under RBSKApril 6, 2023 | marketwatch.comCochlear Implant (CI) Systems Market 2023-2030| Expert Analysis of Current Trend and Scope to Drive the MarketApril 6, 2023 | marketwatch.comSensorion Announces Candidate Selection for GJB2 Gene Therapy ProgramMarch 22, 2023 | uk.news.yahoo.comDad runs half marathon to help deaf babies like his sonMarch 22, 2023 | nasdaq.comCochlear, Demant contest UK regulator's Oticon deal concernsMarch 21, 2023 | markets.businessinsider.comDr. Jace Wolfe named Senior Vice President at Oberkotter Foundation - Hearing FirstSee More Headlines Receive CHEOF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cochlear and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolOTCMKTS:CHEOF CUSIPN/A CIK1453930 Webwww.cochlear.com Phone(129) 428-6555FaxN/AEmployees4,800Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio124.26 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Diggory William Howitt BE (Hons) (Age 57)MBA, CEO, MD, President & Executive Director Comp: $3.1MMr. Stuart SayersChief Financial OfficerMr. Jan Janssen MSc Elec Eng (Age 59)Chief Technology Officer Comp: $1.32MMs. Karen O'DriscollChief Information OfficerMs. Kristina DevonVice President of Investor RelationsRob McGroryGroup General CounselMs. Jennifer StevensonVP of Corporate Communications & BrandMr. Dean PhizackleaSenior Vice President of Global Strategic MarketingMs. Jennifer HornerySenior Vice President of Global People & CultureMr. Greg Bodkin BE (Hons)MComm (UNSW), Senior Vice President of Global Supply ChainMore ExecutivesKey CompetitorsAinosNASDAQ:AIMDWBICO Group AB (publ)OTCMKTS:CLLKFBone BiologicsNASDAQ:BBLGWCaliber Imaging & DiagnosticsOTCMKTS:LCDXCell MedXOTCMKTS:CMXCView All Competitors CHEOF Stock Analysis - Frequently Asked Questions How have CHEOF shares performed in 2024? Cochlear's stock was trading at $198.50 at the start of the year. Since then, CHEOF stock has increased by 2.8% and is now trading at $204.04. View the best growth stocks for 2024 here. Is Cochlear a good dividend stock? Cochlear (OTCMKTS:CHEOF) pays an annual dividend of $1.27 per share and currently has a dividend yield of 2.07%. The dividend payout ratio is 77.34%. Payout ratios above 75% are not desirable because they may not be sustainable. How do I buy shares of Cochlear? Shares of CHEOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:CHEOF) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cochlear Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
